PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
21-Jul-2021 Vetter’s New Clinical Manufacturing Site Now Fully Integrated Vetter
21-Jul-2021 UK Biobank-PPP expands proteomics study of 53,000 participants to Olink Explore 3072 Olink Holding AB
21-Jul-2021 ViiV Healthcare presents data from second Dovato (dolutegravir/lamivudine) switch study confirming non-inferior efficacy and no virologic failure versus a broad range of regimens of at least 3 drugs ViiV Healthcare
21-Jul-2021 ViiV Healthcare study shows new long-acting HIV regimen Cabenuva (cabotegravir/rilpivirine) can be successfully implemented in broad range of US healthcare practices, even during COVID-19 ViiV Healthcare
21-Jul-2021 Vetter’s New Clinical Manufacturing Site Now Fully Integrated B3C newswire
21-Jul-2021 Minaris Will Be the Commercial Manufacturer in Europe for Skysona™, bluebird bio’s Gene Therapy for CALD B3C newswire
21-Jul-2021 Odile Bain Memorial Prize 2021: Brilliant early-career scientists in parasitology recognized Boehringer Ingelheim
21-Jul-2021 Takeda Expands Moderna’s COVID-19 Vaccine Supply in Japan in Partnership with the Japanese Government Takeda
21-Jul-2021 BRAIN Biotech AG: Novel Genome Editing Tool: Filing of International Patent Application BRAIN Biotech AG
20-Jul-2021 Half Year Trading Update ALLIANCE PHARMA PLC
20-Jul-2021 PANAKÈS PARTNERS ANNOUNCES THE FIRST CLOSING OF ITS NEW “PURPLE” GLOBAL BIOTECH/ MEDTECH FUND AT €150 MILLION ($180 MILLION) Panakès
20-Jul-2021 MorphoSys gains enterprise supply chain agility in only eight weeks MorphoSys
20-Jul-2021 Bachem recognised as a winner at the Swiss Biotech Success Stories Awards 2021 Bachem
20-Jul-2021 SP’s fill-finish system chosen by NIBRT to deliver advanced training in biopharmaceutical production SP Scientific Products (SP)
20-Jul-2021 ISA Pharmaceuticals, in partnership with Erasmus MC, is awarded TKI grant and expands clinical pipeline ISA Pharmaceuticals
20-Jul-2021 Almirall receives European Commission approval of Klisyri®▼ (tirbanibulin), an innovative topical treatment for actinic keratosis Almirall
20-Jul-2021 PureTech Founded Entity Gelesis, the Maker of Plenity®, to Become a Publicly Traded Company via Merger with Capstar Special Purpose Acquisition Corp. PureTech
20-Jul-2021 Subscription to raise £1,000,000 to progress proprietary TYK2/JAK1 programmes into clinical development Sareum Holdings plc
20-Jul-2021 Almost 70% of Doctors Say Covid-19 Vaccine Rates Would Be Higher If They Could Administer to Their Own Patients, New Survey Shows B3C newswire
20-Jul-2021 WHO’S TOP OF THE INBOX? RESEARCH RANKS CLINICIAN SATISFACTION WITH PHARMA’S DIGITAL CONTENT Bryter